Quantcast

Latest autoimmune disease Stories

2010-07-08 07:00:00

AURORA, Colo., July 8 /PRNewswire/ -- Western States Biopharmaceuticals, Inc. (WSBI), a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM(TM) autoimmune disease drug discovery targets. WSBI's Chief Scientific Officer and a...

2010-06-02 04:30:00

LOS ANGELES, June 2 /PRNewswire/ -- Two new studies suggest that excess levels of a protein associated with inflammation, TNF, may produce cognitive decline. TNF regulates both inflammation and brain function. TNF is elevated in the blood in many autoimmune diseases, and in the fluid surrounding the brain in Alzheimer's disease. The new studies, from medical centers in Taiwan and the Netherlands, examined cognitive function in patients with either of two autoimmune diseases, rheumatoid...

2010-03-23 16:00:00

HAYWARD, Calif., March 23 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has hired Georgina Kilfoil to the newly created position of Senior Vice President of Product Development and Clinical Operations. "Georgina brings over 18 years of project management and clinical research experience, making her a valuable and welcome addition to our senior...

2010-03-17 06:30:00

SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Barclays Capital 2010 Global Healthcare Conference in Miami, Florida on Tuesday, March 23 at 10:45 a.m. EDT. To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several...

2010-03-03 07:30:00

Milestone Report Addresses Increasing Prevalence, Skyrocketing Costs, New Treatments and Possible Causes of 100+ Diseases WASHINGTON, March 3 /PRNewswire-USNewswire/ -- A groundbreaking new report from the American Autoimmune Related Diseases Association (AARDA), examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to...

2010-02-27 08:09:56

A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology. Multiple sclerosis is a disease due to...

2010-02-16 01:01:00

SOUTH SAN FRANCISCO, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its senior management team will host a conference call, and simultaneous audio webcast, today at 8:30 a.m. EST (5:30 a.m. PST) to discuss its partnership with AstraZeneca for Rigel's late-stage investigational product, fostamatinib disodium (R788), for the treatment of rheumatoid arthritis and additional indications. Conference Call and Webcast Information To access the...

2010-02-05 06:30:00

SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the 12th Annual BIO CEO & Investor Conference in New York City on Monday, February 8th at 10:00 a.m. EST. To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several...

2010-01-25 15:03:00

$1.5 million approved for CDC in 2010 federal appropriations bill WASHINGTON, Jan. 25 /PRNewswire-USNewswire/ -- Thousands of Oregonians suffering from psoriasis and psoriatic arthritis got a boost for the new year from the federal government when it approved $1.5 million to launch the first-ever psoriasis patient registry at the Centers for Disease Control (CDC). The approval of the $1.5 million by Congress was realized after months of advocacy by Oregon lawmakers, U.S. Rep. David Wu...

2009-12-21 06:30:00

INDIANAPOLIS and WILMINGTON, Del., Dec. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (Nasdaq: INCY) announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases. The lead compound, INCB28050, is currently being studied in a six-month...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.